{"id":"W4287730147","doi":"10.1016/s1470-2045(22)00139-5","title":"Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup","year":2022,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"Daiichi Sankyo Europe; National Cancer Institute; Chugai Pharmaceutical; Genentech; National Institutes of Health; Mereo BioPharma; Medac; PharmaMar; Eisai; Seagen; Verastem Oncology; Pfizer; NuCana; Incyte; National Medical Research Council; Karyopharm Therapeutics; Kissei; National Institute for Health and Care Research; Clovis Oncology; Nippon Shinyaku; AstraZeneca; Novocure; Mersana Therapeutics; Amgen; Deciphera Pharmaceuticals; Medical Research Council; Teva Pharmaceutical Industries; Fuji Pharma; GlaxoSmithKline; European Commission; PTC Therapeutics; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Consensus conference; Concordance; Ovarian cancer; Medicine; Clinical trial; Deliberation; Gynecologic cancer; Family medicine; Clinical research; MEDLINE; Gynecology; Cancer; Oncology; Internal medicine; Political science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005700576,0.0003671179,0.003055397,0.0001492869,0.0003866121,0.00003403499,0.0009240916,0.0004774927,0.0105088],"category_scores_gemma":[0.0005772085,0.0001867897,0.0004683809,0.0008622064,0.0005461856,0.00001544096,0.000623845,0.0038432,0.0001290672],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003570578,"about_ca_system_score_gemma":0.004175359,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01102771,"about_ca_topic_score_gemma":0.02105686,"domain_scores_codex":[0.9899548,0.006939937,0.001199035,0.0008118834,0.0003414432,0.0007529315],"domain_scores_gemma":[0.9768097,0.02116971,0.0005195374,0.001294541,0.00008203444,0.0001244963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001439265,0.0004782203,0.003102483,0.0003607587,0.0008411699,0.0002348264,0.0001951853,0.000001068367,2.711443e-8,0.0006893902,0.1536149,0.8403381],"study_design_scores_gemma":[0.002538078,0.0006218094,0.003687607,0.002910861,0.001326029,0.00004764087,0.0002540234,0.000005371134,5.978615e-8,0.000480693,0.987957,0.0001708216],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007887182,0.8329444,5.600161e-7,0.1563041,0.003107541,0.002260077,0.000786947,0.00003169258,0.004485809],"genre_scores_gemma":[0.0001808186,0.9813614,0.0001737081,0.005068397,0.003739648,0.008494414,0.0003614031,0.00005733766,0.0005628607],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8401672,"threshold_uncertainty_score":0.998455,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5870445998710079,"score_gpt":0.5953735657196614,"score_spread":0.008328965848653502,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}